Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial cell membrane and wall** together comprise the cell envelope, the essential structural boundary separating the bacterial cytoplasm from its environment. The **cell wall** is made primarily of peptidoglycan, a rigid mesh of sugar (N-acetylglucosamine and N-acetylmuramic acid) strands crosslinked by peptides, providing mechanical strength, maintaining cell shape, and protecting the cell from osmotic lysis[1][2][3][4][7]. In Gram-positive bacteria, the cell wall is thick and contains teichoic acids; in Gram-negative bacteria, the wall is thin, surrounded by an outer membrane rich in lipopolysaccharide (LPS), and contains an intervening periplasmic space[1][2][7]. The **cell membrane** (plasma membrane) lies beneath the cell wall and consists of a phospholipid bilayer with embedded proteins, functioning in energy transduction, selective transport of solutes, and biosynthesis of cell wall components[5][6]. These structures are major **antibiotic targets**: many first-line antibiotics (such as β-lactams and glycopeptides) act by disrupting cell wall synthesis, while others disrupt the membrane[2][3][5][7]. Selective toxicity is achieved because human cells lack cell walls, but cell envelope targeting can trigger immune responses, and widespread drug resistance poses serious clinical challenges. **Note:** "Bacterial cell membrane and wall" is not the canonical name of a specific single molecular target, but refers to multiple structural macromolecular assemblies. Each represents a complex, druggable feature but not a single protein or gene. For precise target mapping, specific components (e.g., "peptidoglycan synthase," "lipopolysaccharide," "MurA," "penicillin-binding proteins") should be used. This entry aggregates at a higher structural and functional level than standard drug targets[1][2][3].
Inhibition of cell wall synthesis (e.g., β-lactam antibiotics, glycopeptides) - Disruption of cell membrane integrity (e.g., polymyxins, daptomycin) - Inhibition of lipid synthesis needed for wall/membrane (e.g., bacitracin, fosfomycin) - Disruption of peptidoglycan cross-linking
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and wall.